Table 2

Clinical features at knee and hip level by site-specific chondrocalcinosis status

Chondrocalcinosis (%)No chondrocalcinosis (%)
Feature at knee leveln=159n=1470p valuep value*p value**
Age (years±SD)78.4±8.274.9±7.1<0.0001
Analgesic drugs use23.919.1NS
Previous x-ray with osteophytes5.72.00.0050.009
Deformity left34.518.30.00050.0010.05
Deformity right40.520.1<0.00010.0001
Pain at passive movement left33.715.5<0.00010.00010.05
Pain at passive movement right32.517.10.00010.0030.03
Reduced passive mobility left25.012.80.0030.01
Reduced passive mobility right25.013.90.0080.03
Crepitus left75.070.0NS
Crepitus right73.865.0NS
Self-reported pain33.328.6NS
Chondrocalcinosis (%)No chondrocalcinosis (%)
Feature at hip leveln=59n=1570p valuep value*p value**
Age (years±SD)78.2±7.175.2±7.20.001
Analgesic drugs use15.316.9NS
Pain at passive movement left5.15.8NS
Pain at passive movement right13.66.10.02
Pain at palpation left23.39.50.010.02
Pain at palpation right16.79.5NS
Pain at rotation15.39.9NS
Reduced ext. rotation left11.916.8NS
Reduced ext. rotation right11.918.1NS
Self-reported pain18.418.6NS
  • Analysis is made as chondrocalcinosis in specific location vs specific location for osteoarthritis.

  • p Value, significance chondrocalcinosis vs no chondrocalcinosis subjects; p,* age-adjusted p value; p,** age and radiographic features score-adjusted p value.